Skip to content

Clinical Study About Blood Pressure Measurement Efficacy on Multifunction KEITO

Clinical Study About Blood Pressure Measurement Efficacy on Multifunction KEITO

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01359748
Enrollment
89
Registered
2011-05-25
Start date
2011-03-31
Completion date
2011-03-31
Last updated
2014-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Keywords

Non Invasive Blood Pressure measurement study.

Brief summary

The purpose of this trial is to determine the accuracy of the Blood Pressure (BP) measurement of multifunction KEITO devices under test requirements of the Standard American National Standards Institute(ANSI)/Association for the Advancement of Medical Instrumentation(AAMI)/International Organization for Standardization (ISO): ANSI/AAMI/ISO 81060-2:2009.

Detailed description

Nowadays is important controlling our basic health parameters. Due this, the multifunction KEITO Devices was designed to offer to the general public a convenient way to do so easily in the public sites. One of the most important parameter is the Blood Pressure (BP)measurement. To warrant their efficacity and accuracy, was essential to perform this trial to ensure that the measurements obtained meet with the requirements of the specific U.S. standard about Non-invasive sphygmomanometers. By Validating with auscultatory reference sphygmomanometer, as defined on the ANSI/AAMI/ISO 81060-2:2009 , we have been intending to demonstrate that the multifunction KEITO devices, particularly about the Blood Pressure (BP) Measurement, have the same efficacy and accuracy as the conventional auscultatory sphygmomanometers. To include most of the groups of Blood Pressure (BP) measurements types on this clinical trial, a great variety of BP ranges have been selected, always in accordance with the standard.

Interventions

DEVICEReference sphygmomanometer

\* USED Audible Korotkoff (K5)for Auscultatory sphygmomanometer.

DEVICESphygmomanometer under test

Electronic Oscillometric method.

Sponsors

Aguiflai Iberica, S.L.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 83 Years
Healthy volunteers
Yes

Inclusion criteria

* Wrist circumference: 12 to 20 Cm * At least 5% of the readings shall have Systolic BP\<=100 mmHg * At least 5% of the readings shall have Systolic BP\>=160 mmHg * At least 20% of the readings shall have Systolic BP\>=140 mmHg * At least 5% of the readings shall have Diastolic BP\<=60 mmHg * At least 5% of the readings shall have Diastolic BP\>=100 mmHg * At least 20% of the readings shall have Diastolic BP\>=85 mmHg

Exclusion criteria

* Pregnant Women

Design outcomes

Primary

MeasureTime frameDescription
BP Measurements Using the Reference Auscultatory SphygmomanometerFive minutesThe subject was measured by the two observers at the same time using the reference sphygmomanometer and double stethoscope. The observers agree to take the K5 korotkoff sound. Each observer takes notes of their own measures.
BP Measurement Using Multifunction KEITO30 secondsPrior starting the measurement phase using Multifunction KEITO, the under test device was reset before each new measurement. The subject has to be at rest at least 60 seconds before be measured.

Participant flow

Recruitment details

To recruit the volunteers, we have complied with the limb size distribution required on Standard Association for the American National Standards Institute(ANSI)/Association for the Advancement of Medical Instrumentation (AAMI)/International Organization for Standardization (ISO): ANSI/AAMI/ISO 81060-2:2009 \[5.1.4\]

Participants by arm

ArmCount
Wrist Size <=14.25Cm
Subjects, males or females, with wrist size specified.
20
Wrist Size<=16.40 Cm
Subjects, males or females, with wrist size specified.
48
Wrist Size >=16.5 Cm
Subjects, males or females, with wrist size specified.
10
Wrist Size >=17.75
Subjects, males or females, with wrist size specified.
11
Total89

Baseline characteristics

CharacteristicWrist Size <=14.25CmWrist Size<=16.40 CmWrist Size >=16.5 CmWrist Size >=17.75Total
Age, Categorical
<=18 years
1 Participants0 Participants0 Participants0 Participants1 Participants
Age, Categorical
>=65 years
5 Participants5 Participants1 Participants1 Participants12 Participants
Age, Categorical
Between 18 and 65 years
14 Participants43 Participants9 Participants10 Participants76 Participants
Sex: Female, Male
Female
12 Participants26 Participants1 Participants2 Participants41 Participants
Sex: Female, Male
Male
8 Participants22 Participants9 Participants9 Participants48 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 200 / 480 / 100 / 11
serious
Total, serious adverse events
0 / 200 / 480 / 100 / 11

Outcome results

Primary

BP Measurements Using the Reference Auscultatory Sphygmomanometer

The subject was measured by the two observers at the same time using the reference sphygmomanometer and double stethoscope. The observers agree to take the K5 korotkoff sound. Each observer takes notes of their own measures.

Time frame: Five minutes

ArmMeasureGroupValue (MEAN)Dispersion
SubjectsBP Measurements Using the Reference Auscultatory SphygmomanometerSystolic Maximum (mmHg)186 mmHgStandard Deviation 3.1
SubjectsBP Measurements Using the Reference Auscultatory SphygmomanometerDiastolic Maximum (mmHg)107 mmHgStandard Deviation 3
SubjectsBP Measurements Using the Reference Auscultatory SphygmomanometerSystolic Minimum (mmHg)93 mmHgStandard Deviation 3.1
SubjectsBP Measurements Using the Reference Auscultatory SphygmomanometerDiastolic Minimum (mmHg)53 mmHgStandard Deviation 3
Primary

BP Measurement Using Multifunction KEITO

Prior starting the measurement phase using Multifunction KEITO, the under test device was reset before each new measurement. The subject has to be at rest at least 60 seconds before be measured.

Time frame: 30 seconds

ArmMeasureGroupValue (MEAN)Dispersion
SubjectsBP Measurement Using Multifunction KEITOSystolic Maximum174 mmHgStandard Deviation 5.2
SubjectsBP Measurement Using Multifunction KEITODiastolic Maximum98 mmHgStandard Deviation 4.5
SubjectsBP Measurement Using Multifunction KEITOSystolic Minimum94 mmHgStandard Deviation 5.2
SubjectsBP Measurement Using Multifunction KEITODiastolic Minimum55 mmHgStandard Deviation 4.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026